Int'l Flavors & Fragrances (IFF) Tops Q1 EPS by 7c, Offers Guidance
Tweet
Share
E-mail
Get Alerts IFF Hot Sheet
Price: $81.83 -1.14%
Revenue Growth %: -2.9%
Financial Fact:
Research and development expenses: 64.42M
Today's EPS Names:
EPAC, SAR, KRUS, More
Revenue Growth %: -2.9%
Financial Fact:
Research and development expenses: 64.42M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Int'l Flavors & Fragrances (NYSE: IFF) reported Q1 EPS of $1.47, $0.07 better than the analyst estimate of $1.40. Revenue for the quarter came in at $783.3 million versus the consensus estimate of $776.3 million.
The Company’s full year 2016 guidance:
| Currency Neutral | FX Impact | Reported* | |||||||||||||||||||
| Organic | M&A | Total | |||||||||||||||||||
| Sales | 2.0 - 3.0% | ~1.5% | 3.5 - 4.5% | ~(2)% | 1.5 - 2.5% | ||||||||||||||||
| Operating Profit | 3.5 - 5.5% | ~1.5% | 5.0 - 7.0% | ~(3)% | 2.0 - 4.0% | ||||||||||||||||
| EPS | 5.0 - 7.0% | ~1.5% | 6.5 - 8.5% | ~(3)% | 3.5 - 5.5% | ||||||||||||||||
| | |||||||||||||||||||||
For earnings history and earnings-related data on Int'l Flavors & Fragrances (IFF) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
- Raymond James Starts Old National Bancorp (ONB) at Market Perform
- TaiMed Biologics gets TFDA drug license notice for HIV therapy Trogarzo
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
